Jan 11, 2022 / 04:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Welcome back, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to have our next speaker, is going to be the CEO of Penumbra, Adam Elsesser.
Adam, I'm going to turnover to you for formal presentation, and I'll join you in a few for Q&A. Just a reminder, feel free to submit questions online or e-mail me, and I'll do my best to get to all of them. Adam, turn it over to you.
Adam Elsesser - Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Great. Well, good morning, everyone. I want to thank JPMorgan for including us in this year's meeting. And thank you, Robbie, of course, for your coverage of Penumbra. I don't see the slides. Can we put the slides up? There we go. So let's go to the next slide. That's our safe harbor disclosure. Next slide.
So headquartered in Alameda, California, Penumbra is delivering innovative products to patients in over 100 markets around the world, thanks to the extraordinary work of more than 3,500 teammates.
Penumbra Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot